Biocure Announces: Breakthrough Pre-Clinical Trial Results for CAR-T Cells Treatment of Acute Leukemia Biotech Investing
United Therapeutics and MannKind Announce Closing of License and Collaboration Agreement Pharmaceutical Investing
Aimmune Therapeutics Announces Initiation of Phase 2 Study With Regeneron and Sanofi of AR101 Pharmaceutical Investing
Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1 Study of ARO-ANG3 Life Science Investing
Alnylam Announces Plan to Initiate Rolling Submission of a New Drug Application Pharmaceutical Investing
PreveCeutical to Visit Penta 5 Group’s Packaging Facility for Due Diligence on Proposed Acquisition Biotech Investing
Iovance Biotherapeutics Announces Pricing of Its Public Offering of Approximately $220 Million of Common Stock Pharmaceutical Investing
